The DOI matches its Crossref record; 182 of the 182 references it cites were found in a registry or an index.
Insulin receptor and cancer
Open accessAbstract
The widespread epidemic of obesity and type 2 diabetes has raised concern for the impact of these disorders as risk factors for cancer and has renewed the interest for studies regarding the involvement of hyperinsulinemia and insulin receptor (IR) in cancer progression. Overexpression of IR in cancer cells may explain their increased sensitivity to hyperinsulinemia. Moreover, IR isoform A (IR-A) together with autocrine production of its ligand IGF2 is emerging as an important mechanism of normal and cancer stem cell expansion and is a feature of several malignancies.De novo activation of the IR-A/IGF2 autocrine loop also represents a mechanism of resistance to anticancer therapies. Increasing knowledge of the IR role in cancer has important implications for cancer prevention, which should include control of insulin resistance and hyperinsulinemia in the population and meticulous evaluation of new antidiabetic drugs for their metabolic:mitogenic ratio. We are now aware that several anticancer treatments may induce or worsen insulin resistance that may limit therapy efficacy. Future anticancer therapies need to target the IR-A pathway in order to inhibit the tumor promoting effect of IR without impairing the metabolic effect of insulin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Bi-directional Regulation of Brown Fat Adipogenesis by the Insulin Receptor
Entingh, A. J., Taniguchi, C. M., & Kahn, C. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303056200 · Cited by 59
RetractedDifferential endocytosis and signaling dynamics of insulin receptor variants IR-A and IR-B
Giudice, J., Leskow, F. C., Arndt‐Jovin, D. J., Jovin, T. M., & Jares-Erijman, E. A. (2011) · Journal of Cell Science · doi:10.1242/jcs.076869 · Cited by 36
Retracted(2015) · American Journal Of Pathology · doi:10.2353/ajpath · Cited by 4,908
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
Liu, J.-P., Baker, J., Perkins, A. S., Robertson, E. J., & Efstratiadis, A. (1993) · Cell · doi:10.1016/s0092-8674(05)80084-4 · Cited by 2,855
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
Role of insulin-like growth factors in embryonic and postnatal growth
Baker, J., Liu, J.-P., Robertson, E. J., & Efstratiadis, A. (1993) · Cell · doi:10.1016/s0092-8674(05)80085-6 · Cited by 2,463
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
Hawley, S. A., Boudeau, J., Reid, J. L., Mustard, K. J., Udd, L., Mäkelä, T. P., Alessi, D. R., & Hardie, D. G. (2003) · Journal of Biology · doi:10.1186/1475-4924-2-28 · Cited by 1,665
A Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast Cancer
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052258 · Cited by 1,577
Insulin-like growth factors and neoplasia
Pollak, M. N., Schernhammer, E. S., & Hankinson, S. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1387 · Cited by 1,463
Cancer stem cells: an old idea–a paradigm shift
Wicha, M. S., Liu, S., & Dontu, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3153 · Cited by 1,378
Brogiolo, W., Stocker, H., Ikeya, T., Rintelen, F., Fernandez, R., & Hafen, E. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00068-9 · Cited by 1,255
Kulkarni, R. N., Brüning, J. C., Winnay, J. N., Postic, C., Magnuson, M. A., & Kahn, C. R. (1999) · Cell · doi:10.1016/s0092-8674(00)80546-2 · Cited by 1,148
Cusi, K., Maezono, K., Osman, A., Pendergrass, M., Patti, M. E., Pratipanawatr, T., DeFronzo, R. A., Kahn, C. R., & Mandarino, L. J. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7535 · Cited by 1,139
Belfiore, A., Frasca, F., Pandini, G., Sciacca, L., & Vigneri, R. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0047 · Cited by 1,033
Self-citationVigneri, P., Frasca, F., Sciacca, L., Pandini, G., & Vigneri, R. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0087 · Cited by 1,009
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
Samani, A. A., Yakar, S., LeRoith, D., & Brodt, P. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0001 · Cited by 1,005
Bowker, S. L., Majumdar, S. R., Veugelers, P., & Johnson, J. A. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1558 · Cited by 933
Positive and negative regulation of insulin signaling through IRS-1 phosphorylation
Gual, P., Le Marchand-Brustel, Y., & Tanti, J.-F. (2005) · Biochimie · doi:10.1016/j.biochi.2004.10.019 · Cited by 912 · cited 2×
“Mechanisms accounting for this selective impairment of PI3K/Akt activation mainly involve serine and threonine phosphorylation of the IR b-chain and/or IRS1 phosphorylation at serine residues caused by increased circulating levels of not esterified fatty acids (NEFA) and inflammatory cytokines with consequent activati…”
BackgroundFrasca, F., Pandini, G., Scalia, P., Sciacca, L., Mineo, R., Costantino, A., Goldfine, I. D., Belfiore, A., & Vigneri, R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3278 · Cited by 902
Self-citationMultiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression
Liang, J., & Slingerland, J. M. (2003) · Cell Cycle · doi:10.4161/cc.2.4.433 · Cited by 885
Diabetes Mellitus as a Predictor of Cancer Mortality in a Large Cohort of US Adults
Coughlin, S. S., Calle, E. E., Teras, L. R., Petrelli, J., & Thun, M. J. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh161 · Cited by 795
Kurtzhals, P., Schäffer, L., Sørensen, A., Kristensen, C., Jonassen, I., Schmid, C., & Trüb, T. (2000) · Diabetes · doi:10.2337/diabetes.49.6.999 · Cited by 739
Changes in body composition during androgen deprivation therapy for prostate cancer
Smith, M. R., Finkelstein, J. S., McGovern, F. J., Zietman, A. L., Fallon, M. A., Schoenfeld, D. A., & Kantoff, P. W. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8299 · Cited by 697 · cited 2×
“For instance, androgen deprivation therapy promotes accumulation of subcutaneous abdominal fat (Smith et al. 2002) and decreased insulin sensitivity (Smith et al. 2001), thus increasing the risk of developing T2DM (hazard ratioZ1.”
BackgroundThe IGF‐1 receptor in cancer biology
Baserga, R., Peruzzi, F., & Reiss, K. (2003) · International Journal of Cancer · doi:10.1002/ijc.11487 · Cited by 642
Keating, N. L., O'Malley, A. J., Freedland, S. J., & Smith, M. R. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp404 · Cited by 622
Regulation of Alternative Splicing in Vivo by Overexpression of Antagonistic Splicing Factors
Cáceres, J. F., Stamm, S., Helfman, D. M., & Krainer, A. R. (1994) · Science · doi:10.1126/science.8085156 · Cited by 618
Hemkens, L. G., Grouven, U., Bender, R., Günster, C., Gutschmidt, S., Selke, G. W., & Sawicki, P. T. (2009) · Diabetologia · doi:10.1007/s00125-009-1418-4 · Cited by 607 · cited 1×
“However, these data are controversial and difficult to interpret also for the presence of bias and confounders (Colhoun 2009, Hemkens et al. 2009).”
BackgroundJiang, Z. Y., Lin, Y.-W., Clemont, A., Feener, E. P., Hein, K. D., Igarashi, M., Yamauchi, T., White, M. F., & King, G. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5971 · Cited by 604 · cited 3×
“Circulating insulin may affect cancer growth and spread in these patients because insulin resistance is normally restricted to the metabolic pathway, whereas IR signaling pathways leading to cell proliferation and migration are unaffected and even enhanced (Jiang et al. 1999, Cusi et al. 2000).”
BackgroundMethodEarly neonatal death in mice homozygous for a null allele of the insulin receptor gene
Accili, D., Drago, J., Lee, E. J., Johnson, M. D., Cool, M. H., Salvatore, P., Asico, L. D., José, P. A., Taylor, S. I., & Westphal, H. (1996) · Nature Genetics · doi:10.1038/ng0196-106 · Cited by 595
Bendall, S. C., Stewart, M. H., Menendez, P., George, D., Vijayaragavan, K., Werbowetski-Ogilvie, T., Ramos-Mejia, V., Rouleau, A., Yang, J., Bossé, M., et al. (2007) · Nature · doi:10.1038/nature06027 · Cited by 588
Insulin, Insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal Women
Gunter, M. J., Hoover, D. R., Yu, H., Wassertheil-Smoller, S., Rohan, T. E., Manson, J. E., Li, J., Ho, G. Y. F., Xue, X., Anderson, G. L., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn415 · Cited by 563
Distinct and Overlapping Functions of Insulin and IGF-I Receptors
Nakae, J., Kido, Y., & Accili, D. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.6.0452 · Cited by 554
Alimova, I. N., Liu, B., Fan, Z., Edgerton, S. M., Dillon, T., Lind, S. E., & Thor, A. D. (2009) · Cell Cycle · doi:10.4161/cc.8.6.7933 · Cited by 523
Pandini, G., Frasca, F., Mineo, R., Sciacca, L., Vigneri, R., & Belfiore, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202766200 · Cited by 500
Self-citationSandhu, M. S. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.13.972 · Cited by 496
Smith, J. C., Bennett, S., Evans, L. M., Kynaston, H. G., Parmar, M., Mason, M. D., Cockcroft, J. R., Scanlon, M. F., & Davies, J. S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7851 · Cited by 458
Barbieri, M., Bonafè, M., Franceschi, C., & Paolisso, G. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00296.2003 · Cited by 456
AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome
Ruderman, N., & Prentki, M. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1344 · Cited by 451
Insulin signaling meets mitochondria in metabolism
Cheng, Z., Tseng, Y., & White, M. F. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.06.005 · Cited by 449
The IGF-I receptor in cell growth, transformation and apoptosis
Baserga, R., Hongo, A., Rubini, M., Prisco, M., & Valentinis, B. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00007-3 · Cited by 439
Johnson, J. A., Majumdar, S. R., Simpson, S. H., & Toth, E. L. (2002) · Diabetes Care · doi:10.2337/diacare.25.12.2244 · Cited by 421
Law, J. H., Habibi, G., Hu, K., Masoudi, H., Wang, M. Y. C., Stratford, A. L., Park, E., Gee, J. M. W., Finlay, P., Jones, H. E., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2755 · Cited by 401
Yee, D., Paik, S., Lebovic, G. S., Marcus, R. R., Favoni, R. E., Cullen, K. J., Lippman, M. E., & Rosen, N. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-3-509 · Cited by 399
Growth-Promoting Interaction of IGF-II with the Insulin Receptor during Mouse Embryonic Development
Louvi, A., Accili, D., & Efstratiadis, A. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8666 · Cited by 397
Biochimica et biophysica acta. Protein structure and molecular enzymology
ScienceDirect (2002) · Cited by 395
SDRN Epidemiology Group, & Colhoun, H. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1453-1 · Cited by 393
Interaction of Nuclear Receptors with the Wnt/β-Catenin/Tcf Signaling Axis: Wnt You Like to Know?
Mulholland, D. J., Dedhar, S., Coetzee, G. A., & Nelson, C. C. (2005) · Endocrine Reviews · doi:10.1210/er.2003-0034 · Cited by 377
The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance
Vicent, D., Ilany, J., Kondo, T., Naruse, K., Fisher, S. J., Kisanuki, Y. Y., Bursell, S., Yanagisawa, M., King, G. L., & Kahn, C. R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci15211 · Cited by 356
Elevated insulin receptor content in human breast cancer
Papa, V, Pezzino, V, Costantino, A., Belfiore, A., Giuffrida, D., Frittitta, L., Vannelli, G. B., Brand, R., Goldfine, I. D., & Vigneri, R. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114868 · Cited by 338
Self-citationFrystyk, J. (2004) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2004.06.001 · Cited by 338
Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes
Govindarajan, R., Ratnasinghe, L., Simmons, D. L., Siegel, E. R., Midathada, M. V., Kim, L., Kim, P. J., Owens, R. J., & Lang, N. P. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.2777 · Cited by 336
Impact of Androgen Deprivation Therapy on Cardiovascular Disease and Diabetes
Alibhai, S. M. H., Duong-Hua, M., Sutradhar, R., Fleshner, N. E., Warde, P., Cheung, A. M., & Paszat, L. F. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.0923 · Cited by 334
Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies
Pisani, P. (2008) · Archives of Physiology and Biochemistry · doi:10.1080/13813450801954451 · Cited by 329
Prevention of pancreatic cancer induction in hamsters by metformin
Schneider, M. B., Matsuzaki, H., Haorah, J., Ulrich, A., Standop, J., Ding, X., Adrian, T. E., & Pour, P. M. (2001) · Gastroenterology · doi:10.1053/gast.2001.23258 · Cited by 327
Tissue-Specific Expression of Two Alternatively Spliced Insulin Receptor mRNAs in Man
Moller, D. E., Yokota, A., Caro, J. F., & Flier, J. S. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-8-1263 · Cited by 324
Alternative splicing of human insulin receptor messenger RNA
Seino, S., & Bell, G. I. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92439-x · Cited by 317
Insulin-Like Signaling, Nutrient Homeostasis, and Life Span
Taguchi, A., & White, M. F. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100533 · Cited by 310
Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells.
Huff, K. K., Kaufman, D., Gabbay, K. H., Spencer, E., Lippman, M. E., & Dickson, R. B. (1986) · PubMed · Cited by 305
Associations of Insulin Resistance and Adiponectin With Mortality in Women With Breast Cancer
Duggan, C., Irwin, M. L., Xiao, L., Henderson, K. D., Smith, A. W., Baumgartner, R. N., Baumgartner, K. B., Bernstein, L., Ballard-Barbash, R., & McTiernan, A. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.4473 · Cited by 294
Sciacca, L., Costantino, A., Pandini, G., Mineo, R., Frasca, F., Scalia, P., Sbraccia, P., Goldfine, I. D., Vigneri, R., & Belfiore, A. (1999) · Oncogene · doi:10.1038/sj.onc.1202600 · Cited by 288
Self-citationGicquel, C., BERTAGNA, X. Y., Gaston, V., Coste, J., Louvel, A., Baudin, É., Bertherat, J. Y., Chapuis, Y., Duclos, J. M., Schlumberger, M. J., et al. (2001) · PubMed · Cited by 285
Novosyadlyy, R., Lann, D. E., Vijayakumar, A., Rowzee, A., Lazzarino, D. A., Fierz, Y., Carboni, J. M., Gottardis, M. M., Pennisi, P. A., Molinolo, A. A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2141 · Cited by 282
DiGiovanni, J., Kiguchi, K., Frijhoff, A., Wilker, E., Bol, D. K., Beltrán, L., Moats, S., Ramirez, A., Jorcano, J., & Conti, C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3455 · Cited by 281
Zendehdel, K. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg105 · Cited by 280
Insulin promotion of colon tumors in rats.
Tran, T. T., Medline, A., & Bruce, W. R. (1996) · PubMed · Cited by 275
Leibiger, B., Leibiger, I. B., Moede, T., Kemper, S., Kulkarni, R. N., Kahn, C. R., de Vargas, L. M., & Berggren, P.-O. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00203-9 · Cited by 267
Insulin Receptor Knockout Mice
Kitamura, T., Kahn, C. R., & Accili, D. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142540 · Cited by 260
Weight control and physical activity in cancer prevention: international evaluation of the evidence.
Vainio, H., Kaaks, R., & Bianchini, F. (2002) · PubMed · Cited by 259
The Role of Insulin Receptor Isoforms and Hybrid Insulin/IGF-I Receptors in Human Cancer
Belfiore, A. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780249173 · Cited by 252
Self-citationExpression of insulin-like growth factor-1 receptor in human colorectal cancer
Hakam, A., Yeatman, T. J., Lu, L., Mora, L., Marcet, G., Nicosia, S. V., Karl, R. C., & Coppola, D. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90027-8 · Cited by 239
Vella, V. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.1.245 · Cited by 239
Pietrzkowski, Z. J., Mulholland, G., Gomella, L. G., Jameson, B. A., Wernicke, D., & Baserga, R. (1993) · PubMed · Cited by 236
Nickerson, T., Chang, F., Lorimer, D., Smeekens, S. P., Sawyers, C. L., & Pollak, M. (2001) · PubMed · Cited by 231
Insulin receptor expression by human prostate cancers
Cox, M. E., Gleave, M. E., Zakikhani, M., Bell, R. H., Piura, E., Vickers, E., Cunningham, M., Larsson, O., Fazli, L., & Pollak, M. (2009) · The Prostate · doi:10.1002/pros.20852 · Cited by 223
Tamburini, J., Chapuis, N., Bardet, V., Park, S., Sujobert, P., Willems, L., Ifrah, N., Dreyfus, F., Mayeux, P., Lacombe, C., et al. (2008) · Blood · doi:10.1182/blood-2007-03-080796 · Cited by 221
Birth weight and childhood leukemia: A meta‐analysis and review of the current evidence
Caughey, R. W., & Michels, K. B. (2009) · International Journal of Cancer · doi:10.1002/ijc.24225 · Cited by 218
Insulin receptor expression and function in human breast cancer cell lines.
Milazzo, G., Giorgino, F., Damante, G., Sung, C., Stampfer, M. R., Vigneri, R., Goldfine, I. D., & Belfiore, A. (1992) · PubMed · Cited by 206
Self-citationBenyoucef, S., Surinya, K. H., Hadaschik, D., & Siddle, K. (2007) · Biochemical Journal · doi:10.1042/bj20061709 · Cited by 203
Bruno, S., Maisonneuve, P., Castellana, P., Rotmensz, N., Rossi, S., Maggioni, M., Persico, M., Colombo, A., Monasterolo, F., Casadei-Giunchi, D., et al. (2005) · BMJ · doi:10.1136/bmj.38391.663287.e0 · Cited by 201
Wu, Y., Cui, K. Y., Miyoshi, K., Hennighausen, L. G., Green, J. E., Setser, J., LeRoith, D., & Yakar, S. (2003) · PubMed · Cited by 201
Sulphonylureas and cancer: a case-control study
Monami, M., Lamanna, C., Balzi, D., Marchionni, N., & Mannucci, E. (2009) · Acta Diabetologica · doi:10.1007/s00592-008-0083-2 · Cited by 194
Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor
Ish-Shalom, D., Christoffersen, C. T., Vorwerk, P., Sacerdoti-Sierra, N., Shymko, R. M., Naor, D., & Meyts, P. D. (1997) · Diabetologia · doi:10.1007/s001250051393 · Cited by 193
McDevitt, T. C., Laflamme, M. A., & Murry, C. E. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.09.007 · Cited by 183
The insulin-like growth factor-I receptor as an oncogene
Werner, H., & Bruchim, I. (2009) · Archives of Physiology and Biochemistry · doi:10.1080/13813450902783106 · Cited by 183
(1981) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/67.1.51 · Cited by 180
Haluska, P., Carboni, J. M., Loegering, D. A., Lee, F. Y., Wittman, M., Saulnier, M. G., Frennesson, D. B., Kalli, K. R., Conover, C. A., Attar, R. M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1107 · Cited by 179
The IGF system in thyroid cancer: new concepts
Vella, V, Sciacca, L., Pandini, G., Mineo, R., Squatrito, S., Vigneri, R., & Belfiore, A. (2001) · Molecular Pathology · doi:10.1136/mp.54.3.121 · Cited by 177
Self-citationTennant, M. K. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.10.3774 · Cited by 171
Signaling control of mRNA translation in cancer pathogenesis
Holland, E. C., Sonenberg, N., Pandolfi, P. P., & Thomas, G. (2004) · Oncogene · doi:10.1038/sj.onc.1207590 · Cited by 170
Zhang, H., Pelzer, A. M., Kiang, D. T., & Yee, D. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1712 · Cited by 162
Sciacca, L., Mineo, R., Pandini, G., Murabito, A., Vigneri, R., & Belfiore, A. (2002) · Oncogene · doi:10.1038/sj.onc.1206058 · Cited by 162
Self-citationYan, Y., Sailor, K. A., Vemuganti, R., & Dempsey, R. J. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04872.x · Cited by 160
In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites
Sommerfeld, M. R., Müller, G. A., Tschank, G., Seipke, G., Habermann, P., Kurrle, R., & Tennagels, N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009540 · Cited by 156
Kalli, K. R., Falowo, O. I., Bale, L. K., Zschunke, M. A., Roche, P. C., & Conover, C. A. (2002) · Endocrinology · doi:10.1210/en.2001-211408 · Cited by 154
Transgenic rescue of insulin receptor–deficient mice
Okamoto, H., Nakae, J., Kitamura, T., Park, B.-C., Dragatsis, I., & Accili, D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421645 · Cited by 151
Heuson, J.-C., & Legros, N. (1972) · PubMed · Cited by 151
Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon
Freier, S., Weiss, O., Eran, M., Flyvbjerg, A., Dahan, R., Nephesh, I., Safra, T., Shiloni, E., & Raz, I. (1999) · Gut · doi:10.1136/gut.44.5.704 · Cited by 150
Malaguarnera, R., Frasca, F., Garozzo, A., Gianì, F., Pandini, G., Vella, V., Vigneri, R., & Belfiore, A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1255 · Cited by 150
Self-citationFulzele, K. S., DiGirolamo, D. J., Liu, Z., Xu, J. H., Messina, J. L., & Clemens, T. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700651200 · Cited by 149
Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer
Kabat, G. C., Kim, M., Caan, B. J., Chlebowski, R. T., Gunter, M. J., Ho, G., Rodríguez, B. L., Shikany, J. M., Strickler, H. D., Vitolins, M. Z., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24609 · Cited by 146
The bioactivity of insulin analogues from in vitro receptor binding to in vivo glucose uptake
Drejer, K. (1992) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610080305 · Cited by 145
Intrauterine environments and breast cancer risk: meta-analysis and systematic review
Park, S. K., Kang, D., McGlynn, K. A., García‐Closas, M., Kim, Y.-J., Yoo, K. Y., & Brinton, L. A. (2008) · Breast Cancer Research · doi:10.1186/bcr1850 · Cited by 144
Irwin, M. L., Duggan, C. R., Wang, C., Smith, A. W., McTiernan, A., Baumgartner, R., Baumgartner, K. B., Bernstein, L., & Ballard-Barbash, R. R. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.4752 · Cited by 144
Insulin injections promote the growth of aberrant crypt foci in the colon of rats
Corpet, D. E., Jacquinet, C., Peiffer, G., et al. (1997) · Nutrition and Cancer · doi:10.1080/01635589709514543 · Cited by 139
Rousseau, M., Parent, M., Pollak, M., & Siemiatycki, J. (2005) · International Journal of Cancer · doi:10.1002/ijc.21600 · Cited by 139
Garofalo, C., Manara, M. C., Nicoletti, G., Marino, M. T., Lollini, P., Astolfi, A., Pandini, G., López‐Guerrero, J. A., Schaefer, K.-L., Belfiore, A., et al. (2011) · Oncogene · doi:10.1038/onc.2010.640 · Cited by 138
Self-citationBenecke, H., Flier, J. S., & Moller, D. E. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115819 · Cited by 138
Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer
Hofmann, F., & Garcı́a-Echeverrı́a, C. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03512-9 · Cited by 136
Osborne, C. K., Me, M., Lippman, M. E., & Kahn, C. R. (1978) · PubMed · Cited by 133
Birth weight and childhood leukemia : A meta-analysis and review of the current evidence.
Caughey, & Michels (2009) · International Journal of Cancer · Cited by 131
Dual IGF-I/II–Neutralizing Antibody MEDI-573 Potently Inhibits IGF Signaling and Tumor Growth
Gao, J., Chesebrough, J. W., Cartlidge, S. A., Ricketts, S., Incognito, L., Veldman-Jones, M. H., Blakey, D. C., Tabrizi, M. A., Jallal, B., Trail, P. A., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2274 · Cited by 124
Care of the Cancer Survivor: Metabolic Syndrome after Hormone-Modifying Therapy
Redig, A. J., & Munshi, H. G. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.06.022 · Cited by 120
Heuson, J.-C., Legros, N., & Heimann, R. (1972) · PubMed · Cited by 120
The Relation of Type 2 Diabetes and Cancer
Strickler, H. D., Wylie‐Rosett, J., Rohan, T. E., Hoover, D. R., Smoller, S., Burk, R. D., & Yu, H. (2001) · Diabetes Technology & Therapeutics · doi:10.1089/152091501300209633 · Cited by 115
The kinetics of insulin in man. II. Role of the liver
Ferrannini, E., & Cobelli, C. (1987) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610030202 · Cited by 115
Are sulphonylureas all the same? A cohort study on cardiovascular and cancer‐related mortality
Monami, M., Balzi, D., Lamanna, C., Barchielli, A., Masotti, G., Buiatti, E., Marchionni, N., & Mannucci, E. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.736 · Cited by 112
Vogt, B., Carrascosa, J. M., Ermel, B., Ullrich, A., & Häring, H. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)90639-o · Cited by 109
Kosaki, A., & Webster, N. J. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80638-3 · Cited by 107
Aiello, A., Pandini, G., Frasca, F., Conte, E., Murabito, A., Sacco, A., Genua, M., Vigneri, R., & Belfiore, A. (2006) · Endocrinology · doi:10.1210/en.2005-1610 · Cited by 106
Self-citationSciacca, L., di Prisco, M., Wu, A., Belfiore, A., Vigneri, R., & Baserga, R. (2003) · Endocrinology · doi:10.1210/en.2002-0136 · Cited by 105
Self-citationStandaert, M. L., Schimmel, S. D., & POLLET, R. J. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43357-6 · Cited by 104
Paracrine/autocrine regulation of breast cancer by the insulin-like growth factors
Rasmussen, A. A., & Cullen, K. J. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1005903000777 · Cited by 104
Denley, A., Carroll, J. M., Brierley, G. V., Cosgrove, L., Wallace, J., Forbes, B., & Roberts, C. T. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01447-06 · Cited by 103
Expression of IGF-I and IGF-II mRNA in breast tissue
Paik, S. (1992) · Breast Cancer Research and Treatment · doi:10.1007/bf01833331 · Cited by 103
Avnet, S., Sciacca, L., Salerno, M., Gancitano, G., Cassarino, M. F., Longhi, A., Zakikhani, M., Carboni, J. M., Gottardis, M. M., Giunti, A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2645 · Cited by 103
A Kinase-Independent Role for Unoccupied Insulin and IGF-1 Receptors in the Control of Apoptosis
Boucher, J., Macotela, Y., Bézy, O., Mori, M. A., Kriauciunas, K. M., & Kahn, C. R. (2010) · Science Signaling · doi:10.1126/scisignal.2001173 · Cited by 102
Liao, Y., Abel, U. R., Grobholz, R., et al. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.07.023 · Cited by 100
Rosiglitazone and Risk of Cancer
Monami, M., Lamanna, C., Marchionni, N., & Mannucci, E. (2008) · Diabetes Care · doi:10.2337/dc07-2308 · Cited by 97
Pandini, G., Médico, E., Conte, E., Sciacca, L., Vigneri, R., & Belfiore, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304980200 · Cited by 94
Self-citationInsulin-Sensitizing Therapy Attenuates Type 2 Diabetes–Mediated Mammary Tumor Progression
Fierz, Y., Novosyadlyy, R., Vijayakumar, A., Yakar, S., & LeRoith, D. (2009) · Diabetes · doi:10.2337/db09-1291 · Cited by 93
Sayer, R. A., Lancaster, J. M., Pittman, J., et al. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.10.012 · Cited by 93
Kaplan, S. A. (1984) · The Journal of Pediatrics · doi:10.1016/s0022-3476(84)81090-2 · Cited by 92
Ramos-Nino, M. E., MacLean, C. D., & Littenberg, B. (2007) · BMC Medicine · doi:10.1186/1741-7015-5-17 · Cited by 92
Giorgino, F., Belfiore, A., Milazzo, G., Costantino, A., Maddux, B. A., Whittaker, J., Goldfine, I. D., & Vigneri, R. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-3-452 · Cited by 92
Self-citationFeng, Y., Zhu, Z., Xiao, X., Choudhry, V., Barrett, J. C., & Dimitrov, D. S. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0252 · Cited by 92
Isoform-specific insulin receptor signaling involves different plasma membrane domains
Uhles, S., Moede, T., Leibiger, B., Berggren, P., & Leibiger, I. B. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200306093 · Cited by 91
Insulin receptor expression and clinical outcome in node-negative breast cancer.
Mathieu, M. C., Clark, G. M., Allred, D. C., Goldfine, I. D., & Vigneri, R. (1997) · PubMed · Cited by 91
Kaaks, R., & Lukanova, A. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04118.x · Cited by 90
Jensen, M., Hansen, B., MEYTS, P. D., Schäffer, L., & Ursø, B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704599200 · Cited by 89
Cardillo, M. R., Monti, S., Silverio, F. D., Gentile, V., Sciarra, F., & Toscano, V. (2003) · PubMed · Cited by 89
Tode, B., Serio, M., Rotella, C. M., Galli, G., Franceschelli, F., Tanini, A., & Toccafondi, R. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-3-639 · Cited by 81
IGF-I in epithelial ovarian cancer and its role in disease progression
Brokaw, J. L., Katsaros, D., Wiley, A., et al. (2007) · Growth Factors · doi:10.1080/08977190701838402 · Cited by 80
Benoliel, A., Kahn‐Perlès, B., Imbert, J., & Verrando, P. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.17.2089 · Cited by 79
Chronic activation of AMP-activated kinase as a strategy for slowing aging
McCarty, M. F. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.01.043 · Cited by 78
Proliferative effects of insulin analogues on mammary epithelial cells
Mayer, D., Shukla, A. K., & Enzmann, H. G. (2008) · Archives of Physiology and Biochemistry · doi:10.1080/13813450801900645 · Cited by 78
Stachelscheid, H., Ibrahim, H., Koch, L., Schmitz, A., Tscharntke, M., Wunderlich, F. T., Scott, J. A., Michels, C., Wickenhauser, C., Haase, I., et al. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.141 · Cited by 77
Goalstone, M. L., Carel, K. D., Leitner, J. W., & Draznin, B. (1997) · Endocrinology · doi:10.1210/endo.138.12.5621 · Cited by 76
Sacco, A., Morcavallo, A., Pandini, G., Vigneri, R., & Belfiore, A. (2009) · Endocrinology · doi:10.1210/en.2009-0377 · Cited by 74
Self-citationSavarese, T. M., Strohsnitter, W. C., Low, H. P., Liu, Q., Baik, I., Okulicz, W. C., Chelmow, D. P., Λάγιου, Π., Quesenberry, P. J., Noller, K. L., et al. (2007) · Breast Cancer Research · doi:10.1186/bcr1674 · Cited by 73
Birth weight and the risk of testicular cancer: A meta‐analysis
Michos, A., Xue, F., & Michels, K. B. (2007) · International Journal of Cancer · doi:10.1002/ijc.22771 · Cited by 71
Birth Weight as a Risk Factor for Breast Cancer: A Meta-Analysis of 18 Epidemiological Studies
Xu, X., Dailey, A. B., Peoples‐Sheps, M. D., Talbott, E. O., Li, N., & Roth, J. (2009) · Journal of Women s Health · doi:10.1089/jwh.2008.1034 · Cited by 70
Li, S., Goko, H., Xu, Z., et al. (1998) · Cell and Tissue Research · doi:10.1007/s004410051016 · Cited by 66
The B Isoform of the Insulin Receptor Signals More Efficiently Than the A Isoform in HepG2 Cells
Kosaki, A., Pillay, T. S., Xu, L., & Webster, N. J. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.35.20816 · Cited by 64
Miyamoto, S., Nakamura, M., Shitara, K., Nakamura, K., Ohki, Y., Ishii, G., Goya, M., Kodama, K., Sangai, T., Maeda, H., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1701 · Cited by 63
Vigneri, P. G., Frasca, F., Sciacca, L., Frittitta, L., & Vigneri, R. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.10.013 · Cited by 61
Scotlandi, K., Manara, M. C., Serra, M., Marino, M. T., Ventura, S., Garofalo, C., Alberghini, M., Magagnoli, G., Ferrari, S., López‐Guerrero, J. A., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.01.007 · Cited by 60
Michell, N. P., LANGMAN, M. J. S., & Eggo, M. C. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.337 · Cited by 59
Impact of IGF-I/IGF-IR Circuit on the Angiogenetic Properties of Ewing’s Sarcoma Cells
Strammiello, R., Benini, S., Manara, M. C., Perdichizzi, S., Serra, M., Spisni, E., Picci, P., & Scotlandi, K. (2003) · Hormone and Metabolic Research · doi:10.1055/s-2004-814149 · Cited by 57
Belfiore, A., Costantino, A., Frasca, F., Pandini, G., Mineo, R., Vigneri, P. G., Maddux, B. A., Goldfine, I. D., & Vigneri, R. (1996) · Molecular Endocrinology · doi:10.1210/me.10.11.1318 · Cited by 56
Self-citationMorcavallo, A., Gaspari, M., Pandini, G., Palummo, A., Cuda, G., Larsen, M. R., Vigneri, R., & Belfiore, A. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0484 · Cited by 54
Self-citationJiráček, J., Žáková, L., Antolíková, E., Watson, C. J. E., Turkenburg, J. P., Dodson, G. G., & Brzozowski, A. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911785107 · Cited by 54
Role of Prepancreatic (Pro)Insulin and the Insulin Receptor in Prevention of Embryonic Apoptosis
Morales, A. V., Serna, J., Alarcón, C., de la Rosa, E. J., & de Pablo, F. (1997) · Endocrinology · doi:10.1210/endo.138.9.5396 · Cited by 51
Mastick, C. C., Kato, H., Roberts, C. T., LeRoith, D., & Saltiel, A. R. (1994) · Endocrinology · doi:10.1210/endo.135.1.7516864 · Cited by 46
Shin, A., Ren, Z., Shu, X., Cai, Q., Gao, Y., & Zheng, W. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9427-1 · Cited by 41
Energy balance, insulin resistance biomarkers, and breast cancer risk
Fair, A. M., Dai, Q., Shu, X., Matthews, C. E., Yu, H., Jin, F., Gao, Y., & Zheng, W. (2007) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2007.04.003 · Cited by 40
Human insulin receptor radioimmunoassay: applicability to insulin-resistant states
PEZZINO, V., Papa, V., Trischitta, V., Brunetti, A., Goodman, P. A., Treutelaar, M. K., Williams, J. A., Maddux, B. A., Vigneri, R., & Goldfine, I. D. (1989) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1989.257.3.e451 · Cited by 39
The insulin receptor is essential for virus-induced tumorigenesis of Kaposi's sarcoma
Rose, P. P., Carroll, J. M., Carroll, P. A., DeFilippis, V. R., Lagunoff, M., Moses, A. V., Roberts, C. T., & Früh, K. (2006) · Oncogene · doi:10.1038/sj.onc.1210006 · Cited by 36
Insulin Glulisine—A Comprehensive Preclinical Evaluation
Stammberger, I., Seipke, G., & Bartels, T. (2006) · International Journal of Toxicology · doi:10.1080/10915810500488379 · Cited by 36
Role of c-Abl in Directing Metabolic versus Mitogenic Effects in Insulin Receptor Signaling
Frasca, F., Pandini, G., Malaguarnera, R., Mandarino, A., Messina, R. L., Sciacca, L., Belfiore, A., & Vigneri, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705008200 · Cited by 35
Self-citationIncreased Insulin Sensitivity in IGF-I Receptor–Deficient Brown Adipocytes
Mur, C., Valverde, Á. M., Kahn, C. R., & Benito, M. (2002) · Diabetes · doi:10.2337/diabetes.51.3.743 · Cited by 35
Papa, V., Costantino, A., & Belfiore, A. (1997) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(97)00114-8 · Cited by 31
Self-citationInsulin receptor substrate (IRS)‐1 regulates murine embryonic stem (mES) cells self‐renewal
Rubin, R., Arzumanyan, A. L., Soliera, A. R., Ross, B. N., Peruzzi, F., & di Prisco, M. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21185 · Cited by 30
Mu, L., Katsaros, D., Wiley, A., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0046-x · Cited by 29
Chong, Y. M., Williams, S. L. J., Elkak, A. E., Sharma, A. K., & Mokbel, K. (2006) · PubMed · Cited by 29
Vrieling, A., Voskuil, D. W., Bosma, A. R., Majoor, D. M., van Doorn, J., Cats, A., Depla, A. C. T. M., Timmer, R., Witteman, B. J. M., Wesseling, J., et al. (2008) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2008.08.004 · Cited by 27
Fetal Proinsulin and Birth Weight
Dornhorst, A., Nicholls, J. S. D., Ali, K., Andres, C., Adamson, D. L., Kelly, L. F., Niththyananthan, R., Beard, R. W., & Gray, I. P. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb02016.x · Cited by 19
Sharon, R., Pillemer, G., Ish‐Shalom, D., Kalman, R., Ziv, E., Berry, E. M., & Naor, D. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910530523 · Cited by 18
Role of Prepancreatic (Pro)Insulin and the Insulin Receptor in Prevention of Embryonic Apoptosis
Morales, A. V. (1997) · Endocrinology · doi:10.1210/en.138.9.3967 · Cited by 14
Timing‐Dependent Modulation of Insulin Mitogenic Versus Metabolic Signalling
MEYTS, P. D., & Shymko, R. M. (2000) · Novartis Foundation symposium · doi:10.1002/0470870796.ch4 · Cited by 12
Rôle de la voie de l’IGF dans les cancers bronchiques
Moro‐Sibilot, D., Coudurier, M., & Lantuéjoul, S. (2010) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2010.07.005 · Cited by 7
Cited by
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
Glaviano, A., Foo, A. S. C., Lam, H. Y., Yap, K. C. H., Jacot, W., Jones, R. H., Eng, H., Nair, M. G., Makvandi, P., Geoerger, B., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01827-6 · Cited by 2,138
Obesity, type 2 diabetes, and cancer: the insulin and IGF connection
Cohen, D. H., & LeRoith, D. (2012) · Endocrine-Related Cancer · doi:10.1530/erc-11-0374 · Cited by 301
Livingstone, C. (2013) · Endocrine-Related Cancer · doi:10.1530/erc-13-0231 · Cited by 296
Janssen, J. A. M. J. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157797 · Cited by 294
Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta-Analysis
Soranna, D., Scotti, L., Zambon, A., Bosetti, C., Grassi, G., Catapano, A., La Vecchia, C., Mancia, G., & Corrao, G. (2012) · The Oncologist · doi:10.1634/theoncologist.2011-0462 · Cited by 274
Metadata
- Authors
- Belfiore, A., & Malaguarnera, R.
- Venue
- Endocrine-Related Cancer
- Publisher
- Bioscientifica
- Published
- 2011-05-16
- Volume
- 18
- Issue
- 4
- Pages
- R125-R147
- ISSN
- 1351-0088 (ISSN-L)
- 1479-6821
- OpenAlex
- W2119994212
- Cited by
- 272
- References
- 182
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.